ctrl K

Price Alert

Grace Therapeutics Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

3.19

-0.10 (-3.19%)

At close: Aug 20, 2025, 9:40 AM

Grace Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	22.13M	23M	27.88M	30.34M
Short-Term Investments	n/a	n/a	15K	13.32M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	126K	722K	802K	548K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	352K
Total Current Assets	22.71M	24.01M	29.29M	45.28M
Property-Plant & Equipment	15K	24K	567K	565K
Goodwill & Intangibles	49.27M	49.27M	49.27M	82.77M
Total Long-Term Assets	49.28M	49.29M	49.83M	83.34M
Total Assets	71.99M	73.3M	79.12M	128.62M
Account Payables	601K	1.01M	1.24M	1.68M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	75K	104K
Other Current Liabilities	n/a	n/a	-75K	-104K
Total Current Liabilities	1.93M	1.68M	3.41M	3.26M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.14M	4.36M	n/a	10K
Total Long-Term Liabilities	3.45M	9.87M	7.76M	17.09M
Total Liabilities	5.38M	11.56M	11.17M	20.35M
Total Debt	n/a	n/a	485K	295K
Common Stock	1K	261.04M	258.29M	257.99M
Retained Earnings	-220.69M	-211.12M	-198.27M	-155.84M
Comprehensive Income	-6.04M	-6.04M	-6.04M	-6.04M
Shareholders Equity	66.61M	61.74M	67.95M	108.27M
Total Investments	n/a	n/a	15K	13.32M